Bosh sahifaSWOBY • OTCMKTS
add
Swedish Orphan Biovitrum ADR
Yopilish kursi
19,63 $
Yillik diapazon
13,10 $ - 23,59 $
Bozor kapitalizatsiyasi
143,25 mlrd SEK
Oʻrtacha hajm
594,00
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 7,82 mlrd | 5,19% |
Joriy xarajat | 3,75 mlrd | -10,07% |
Sof foyda | 1,86 mlrd | 33,29% |
Sof foyda marjasi | 23,81 | 26,72% |
Har bir ulushga tushum | 5,65 | 41,96% |
EBITDA | 3,13 mlrd | 33,48% |
Amaldagi soliq stavkasi | 14,27% | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,04 mlrd | -8,68% |
Jami aktivlari | 67,43 mlrd | -10,62% |
Jami passivlari | 29,71 mlrd | -15,47% |
Umumiy kapital | 37,72 mlrd | — |
Tarqatilgan aksiyalar | 345,66 mln | — |
Narxi/balansdagi bahosi | 0,18 | — |
Aktivlardan daromad | 9,51% | — |
Kapitaldan daromad | 12,94% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,86 mlrd | 33,29% |
Operatsiyalardan naqd pul | 2,98 mlrd | 65,89% |
Sarmoyadan naqd pul | -1,08 mlrd | -966,34% |
Moliyadan naqd pul | -1,90 mlrd | -65,13% |
Naqd pulning sof oʻzgarishi | 2,00 mln | -99,63% |
Boʻsh pul | 2,86 mlrd | -1,53% |
Haqida
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Tashkil etilgan
1939
Sayt
Xodimlar soni
1 888
